ArticleMolecular oncology2015

Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells.

Luke H Hoeppner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.